IX logo

ORIX Corporation (IX) EBITDA

annual EBITDA:

$6.38B+$272.62M(+4.47%)
March 31, 2025

Summary

  • As of today (August 22, 2025), IX annual EBITDA is $6.38 billion, with the most recent change of +$272.62 million (+4.47%) on March 31, 2025.
  • During the last 3 years, IX annual EBITDA has risen by +$254.40 million (+4.16%).
  • IX annual EBITDA is now -2.28% below its all-time high of $6.52 billion, reached on March 31, 2019.

Performance

IX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIXincome statement metrics

quarterly EBITDA:

$1.91B+$403.19M(+26.71%)
June 1, 2025

Summary

  • As of today (August 22, 2025), IX quarterly EBITDA is $1.91 billion, with the most recent change of +$403.19 million (+26.71%) on June 1, 2025.
  • Over the past year, IX quarterly EBITDA has increased by +$419.81 million (+28.12%).
  • IX quarterly EBITDA is now -31.50% below its all-time high of $2.79 billion, reached on December 31, 2008.

Performance

IX quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIXincome statement metrics

TTM EBITDA:

$6.81B+$419.81M(+6.57%)
June 1, 2025

Summary

  • As of today (August 22, 2025), IX TTM EBITDA is $6.81 billion, with the most recent change of +$419.81 million (+6.57%) on June 1, 2025.
  • Over the past year, IX TTM EBITDA has increased by +$420.31 million (+6.58%).
  • IX TTM EBITDA is now -3.73% below its all-time high of $7.07 billion, reached on September 30, 2021.

Performance

IX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIXincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

IX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.5%+28.1%+6.6%
3 y3 years+4.2%+32.7%+8.4%
5 y5 years+1.5%+26.2%+4.9%

IX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7.5%at high+40.3%at high+18.1%
5 y5-yearat high+7.5%at high+40.3%-3.7%+18.1%
alltimeall time-2.3%+5936.8%-31.5%+255.4%-3.7%+1082.6%

IX EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.91B(+26.7%)
$6.81B(+6.6%)
Mar 2025
$6.38B(+4.5%)
$1.51B(-5.0%)
$6.39B(-2.1%)
Dec 2024
-
$1.59B(-11.4%)
$6.52B(-1.3%)
Sep 2024
-
$1.79B(+20.2%)
$6.61B(+3.5%)
Jun 2024
-
$1.49B(-9.1%)
$6.39B(-1.4%)
Mar 2024
$6.10B(+2.9%)
$1.64B(-2.1%)
$6.48B(-1.1%)
Dec 2023
-
$1.68B(+6.9%)
$6.55B(+1.5%)
Sep 2023
-
$1.57B(-0.9%)
$6.45B(+3.3%)
Jun 2023
-
$1.59B(-7.6%)
$6.25B(+2.4%)
Mar 2023
$5.93B(-3.1%)
$1.72B(+8.6%)
$6.10B(+5.8%)
Dec 2022
-
$1.58B(+16.0%)
$5.77B(-1.9%)
Sep 2022
-
$1.36B(-5.4%)
$5.88B(-6.4%)
Jun 2022
-
$1.44B(+4.4%)
$6.28B(-6.2%)
Mar 2022
$6.12B(-1.5%)
$1.38B(-18.4%)
$6.69B(-4.2%)
Dec 2021
-
$1.69B(-4.2%)
$6.99B(-1.2%)
Sep 2021
-
$1.77B(-4.9%)
$7.07B(+1.3%)
Jun 2021
-
$1.86B(+11.0%)
$6.98B(+5.1%)
Mar 2021
$6.21B(-1.1%)
$1.67B(-5.8%)
$6.64B(+2.0%)
Dec 2020
-
$1.78B(+6.3%)
$6.50B(+1.9%)
Sep 2020
-
$1.67B(+10.2%)
$6.38B(-1.6%)
Jun 2020
-
$1.52B(-1.6%)
$6.49B(-1.4%)
Mar 2020
$6.28B(-3.7%)
$1.54B(-6.9%)
$6.58B(-1.2%)
Dec 2019
-
$1.65B(-6.9%)
$6.66B(+3.1%)
Sep 2019
-
$1.78B(+10.7%)
$6.46B(+1.2%)
Jun 2019
-
$1.60B(-1.1%)
$6.39B(-1.3%)
Mar 2019
$6.52B(+3.3%)
$1.62B(+11.4%)
$6.47B(+1.6%)
Dec 2018
-
$1.46B(-14.4%)
$6.36B(-1.4%)
Sep 2018
-
$1.70B(+1.0%)
$6.45B(+0.9%)
Jun 2018
-
$1.69B(+10.9%)
$6.39B(+1.2%)
Mar 2018
$6.32B(+11.7%)
$1.52B(-1.8%)
$6.32B(+0.9%)
Dec 2017
-
$1.55B(-5.8%)
$6.26B(+0.2%)
Sep 2017
-
$1.64B(+2.2%)
$6.25B(+0.3%)
Jun 2017
-
$1.61B(+10.1%)
$6.23B(+1.0%)
Mar 2017
$5.65B(+18.6%)
$1.46B(-4.9%)
$6.17B(+9.1%)
Dec 2016
-
$1.54B(-5.4%)
$5.65B(+8.2%)
Sep 2016
-
$1.62B(+4.9%)
$5.23B(+8.8%)
Jun 2016
-
$1.55B(+63.4%)
$4.80B(+28.4%)
Mar 2016
$4.76B(-6.8%)
$947.03M(-14.6%)
$3.74B(-21.4%)
Dec 2015
-
$1.11B(-7.6%)
$4.76B(+0.2%)
Sep 2015
-
$1.20B(+147.6%)
$4.75B(+2.8%)
Jun 2015
-
$484.80M(-75.3%)
$4.62B(-25.3%)
Mar 2015
$5.11B(+3.0%)
$1.96B(+78.7%)
$6.18B(+17.6%)
Dec 2014
-
$1.10B(+2.7%)
$5.26B(-1.9%)
Sep 2014
-
$1.07B(-47.8%)
$5.36B(+0.6%)
Jun 2014
-
$2.05B(+97.8%)
$5.32B(+22.1%)
Mar 2014
$4.96B(-6.9%)
$1.04B(-13.6%)
$4.36B(+12.0%)
Dec 2013
-
$1.20B(+15.7%)
$3.89B(+3.0%)
Sep 2013
-
$1.04B(-4.6%)
$3.78B(+14.9%)
Jun 2013
-
$1.09B(+91.2%)
$3.29B(+21.7%)
Mar 2013
$5.33B
$568.19M(-47.7%)
$2.70B(-15.7%)
Dec 2012
-
$1.09B(+98.5%)
$3.20B(+3.4%)
DateAnnualQuarterlyTTM
Sep 2012
-
$547.04M(+9.2%)
$3.10B(-16.3%)
Jun 2012
-
$500.82M(-53.2%)
$3.70B(-11.5%)
Mar 2012
$5.34B(+16.8%)
$1.07B(+9.2%)
$4.18B(+10.1%)
Dec 2011
-
$979.71M(-14.9%)
$3.80B(+3.3%)
Sep 2011
-
$1.15B(+17.2%)
$3.68B(+9.2%)
Jun 2011
-
$982.39M(+43.0%)
$3.37B(+7.5%)
Mar 2011
$4.57B(+51.3%)
$687.21M(-20.0%)
$3.14B(+6.0%)
Dec 2010
-
$859.32M(+2.0%)
$2.96B(+6.9%)
Sep 2010
-
$842.73M(+12.9%)
$2.77B(+19.1%)
Jun 2010
-
$746.64M(+46.6%)
$2.32B(-1.2%)
Mar 2010
$3.02B(-17.7%)
$509.41M(-23.9%)
$2.35B(-15.8%)
Dec 2009
-
$669.17M(+67.8%)
$2.79B(-43.2%)
Sep 2009
-
$398.73M(-48.6%)
$4.92B(-5.9%)
Jun 2009
-
$775.31M(-18.4%)
$5.22B(-0.5%)
Mar 2009
$3.67B(-11.4%)
$949.80M(-66.0%)
$5.25B(-4.1%)
Dec 2008
-
$2.79B(+296.1%)
$5.47B(+277.4%)
Sep 2008
-
$704.91M(-12.2%)
$1.45B(-3.4%)
Jun 2008
-
$802.78M(-31.6%)
$1.50B(+1.3%)
Mar 2008
$4.15B(-7.9%)
$1.17B(-195.3%)
$1.48B(+7.9%)
Dec 2007
-
-$1.23B(-262.8%)
$1.37B(-63.0%)
Sep 2007
-
$755.87M(-3.6%)
$3.71B(-3.5%)
Jun 2007
-
$783.84M(-26.4%)
$3.85B(-3.5%)
Mar 2007
$4.50B(+20.9%)
$1.06B(-4.2%)
$3.99B(+6.5%)
Dec 2006
-
$1.11B(+24.8%)
$3.75B(+10.1%)
Sep 2006
-
$890.04M(-3.8%)
$3.40B(+1.2%)
Jun 2006
-
$925.01M(+12.7%)
$3.36B(+4.7%)
Mar 2006
$3.73B(+19.1%)
$820.41M(+7.1%)
$3.21B(+5.1%)
Dec 2005
-
$765.85M(-9.9%)
$3.05B(+3.9%)
Sep 2005
-
$849.79M(+9.9%)
$2.94B(+7.7%)
Jun 2005
-
$773.06M(+16.2%)
$2.73B(+7.8%)
Mar 2005
$3.13B(+23.5%)
$665.54M(+2.4%)
$2.53B(+35.7%)
Dec 2004
-
$650.00M(+1.4%)
$1.87B(+53.4%)
Sep 2004
-
$640.87M(+11.4%)
$1.22B(+111.4%)
Jun 2004
-
$575.54M
$575.54M
Mar 2004
$2.53B(+5.2%)
-
-
Mar 2003
$2.41B(-50.4%)
-
-
Mar 2002
$4.85B(-5.6%)
-
-
Mar 2001
$5.14B(-0.3%)
-
-
Mar 2000
$5.15B(+16.0%)
-
-
Mar 1999
$4.44B(-6.0%)
-
-
Mar 1998
$4.73B(+1.0%)
-
-
Mar 1997
$4.68B(-7.4%)
-
-
Mar 1996
$5.06B(+2389.8%)
-
-
Mar 1991
$203.05M(-30.4%)
-
-
Mar 1990
$291.58M(-3.8%)
-
-
Mar 1989
$303.16M(+22.4%)
-
-
Sep 1987
$247.62M(+26.4%)
-
-
Sep 1986
$195.85M(+56.3%)
-
-
Sep 1985
$125.29M(+1.2%)
-
-
Sep 1984
$123.82M(+1.0%)
-
-
Sep 1983
$122.63M(+16.1%)
-
-
Sep 1982
$105.61M
-
-

FAQ

  • What is ORIX Corporation annual EBITDA?
  • What is the all time high annual EBITDA for ORIX Corporation?
  • What is ORIX Corporation annual EBITDA year-on-year change?
  • What is ORIX Corporation quarterly EBITDA?
  • What is the all time high quarterly EBITDA for ORIX Corporation?
  • What is ORIX Corporation quarterly EBITDA year-on-year change?
  • What is ORIX Corporation TTM EBITDA?
  • What is the all time high TTM EBITDA for ORIX Corporation?
  • What is ORIX Corporation TTM EBITDA year-on-year change?

What is ORIX Corporation annual EBITDA?

The current annual EBITDA of IX is $6.38B

What is the all time high annual EBITDA for ORIX Corporation?

ORIX Corporation all-time high annual EBITDA is $6.52B

What is ORIX Corporation annual EBITDA year-on-year change?

Over the past year, IX annual EBITDA has changed by +$272.62M (+4.47%)

What is ORIX Corporation quarterly EBITDA?

The current quarterly EBITDA of IX is $1.91B

What is the all time high quarterly EBITDA for ORIX Corporation?

ORIX Corporation all-time high quarterly EBITDA is $2.79B

What is ORIX Corporation quarterly EBITDA year-on-year change?

Over the past year, IX quarterly EBITDA has changed by +$419.81M (+28.12%)

What is ORIX Corporation TTM EBITDA?

The current TTM EBITDA of IX is $6.81B

What is the all time high TTM EBITDA for ORIX Corporation?

ORIX Corporation all-time high TTM EBITDA is $7.07B

What is ORIX Corporation TTM EBITDA year-on-year change?

Over the past year, IX TTM EBITDA has changed by +$420.31M (+6.58%)
On this page